Fee-for-Service Preferred Drug List Update

Having trouble viewing this email? View it as a Web page.

Health Care Authority (HCA) logo

Apple Health (Medicaid) Provider Alert

The Health Care Authority (agency) has corrected the November 1, 2017, Fee-for-Service (FFS) Preferred Drug List (PDL). 

The list was updated to include Mavyret™ and Vosevi™ as preferred products and removes Victrelis® because it is no longer manufactured. These changes were effective for dates of service on and after October 1, 2017.

Please see the agency’s Prescription Drug Program Billing Guide page to access the corrected versions of these FFS PDLs.